bone marrow transplant

(redirected from Hematopoietic stem cell transplantation)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.

bone marrow transplant:

see bone marrowbone marrow,
soft tissue filling the spongy interiors of animal bones. Red marrow is the principal organ that forms blood cells in mammals, including humans (see blood). In children, the bones contain only red marrow.
..... Click the link for more information.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved.
References in periodicals archive ?
Vucinic et al., "High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis," Blood, vol.
Bondanza, "Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation: the long and winding road toward validated immune biomarkers," Frontiers in Immunology, vol.
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
This antigen makes BC8 potentially useful in targeting white blood cells in preparation for hematopoietic stem cell transplantation in a number of blood cancer indications, including acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, Hodgkin's disease, Non-Hodgkin lymphomas and multiple myeloma, revealed the company.
The eligible candidates must comply with the criteria as follows: (1) Age >15 years old; (2) patients underwent first auto-HSCT at Hematopoietic Stem Cell Transplantation Center of Blood Diseases Hospital, Chinese Academy of Medical Sciences between January 1, 1994 and February 28, 2014; (3) follow-up data were available.
TOKYO, Japan, February 6, 2014 -- REGiMMUNE Corporation has begun a Phase 2 study of its proprietary compound RGI-2001 for GvHD associated with hematopoietic stem cell transplantation.
Today, allogeneic hematopoietic stem cell transplantation (HSCT) is commonly used as treatment for hematological malignancies, immunodeficiencies, and inborn errors of metabolism [1].
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001;98:1687-94.
Alain Fischer, MD of the Hopital Necker in Paris, France and colleagues reported long-term results for 919 patients with primary immunodeficiencies treated with hematopoietic stem cell transplantation at 37 European Centers between 1968 and 1999.
The clinical trial HERACLES is a prospective multi-center study in four European countries to include patients that have received a first-line standard treatment of corticosteroids following allogeneic hematopoietic stem cell transplantation.
Omeros announced that the European Commission has adopted a decision designating OMS721 as an Orphan Medicinal Product in the European Union for treatment in hematopoietic stem cell transplantation, or HSCT.

Full browser ?